A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)

NCT00389896 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

HDL Cholesterol

Interventions

DRUG: MK0733 / Duration of Treatment: 18 Weeks
DRUG: Comparator: placebo (unspecified) / Duration of Treatment: 18 Weeks

Sponsor

Organon and Co